Janssen’s new prescription pain treatment to be available in March

Janssen Korea says Jurnista prolonged-release tablets (hydromorphone HCl), a new prescription treatment for severe pain, will be available here in March, under health insurance coverage.

Jurnista was developed by Alza Corporation and utilizes the OROS (Oral Osmotic System) Push-Pull delivery system to release the opioid hydromorphone at a consistent rate.

Following oral dosing of Jurnista...